课题基金 / 基金详情

Clinical specimen tumor-TME acquired resistance

Clinical specimen tumor-TME acquired resistance
临床标本肿瘤-TME获得性耐药
批准号:
10910588
负责人:
Trever G Bivona
金额:
$8.08万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
未结题
起止时间:
2017-09-30 至 2027-08-31

项目成果

Trever G Bivona的其他基金

相似基金

相关文献

期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dissecting the role and mechanism of EML4-ALK condensates in oncogenic signaling and tumor growth
(PQ7) Defining a new mode of RAS signaling in cancer from cytoplasmic protein granules
(PQ7) Defining a new mode of RAS signaling in cancer from cytoplasmic protein granules
(PQ7) Defining a new mode of RAS signaling in cancer from cytoplasmic protein granules
海外基金